Pfizer bought Global Blood Therapeutics Global Blood Therapeutics from 10/5/22

User image

Vladimir Petenev

News editor
press@blackterminal.com

Pfizer completed its acquisition of Global Blood Therapeutics for $5.4, or $68.5 per share.

Global Blood Therapeutics

Review

Source:

{source} pictogram

investors.pfizer.com

Vladimir Petenev

News editor

Write your comment first

News feed

Novaev Group increased its share in the winery Manor Golubitskoe

4/4/24 BELU

Novatek will focus its efforts on Murmansk LNG

4/4/24 NVTK

Delimobile reported for 2023 according by RAS

4/4/24 DELI

Ozone has launched a fresh direction

4/4/24 OZON

Severstal acquired A Group's sales network

4/4/24 CHMF

Board of Directors of KuibyshevAzot recommended that dividends be paid for 2023

4/4/24 KAZT

Tinkoff created its own NPF

4/4/24 T

Government and Novatek to invest ₽24.3 billion to build LNG equipment

4/4/24 NVTK

Delimobil reported 2023 by IFRS

4/4/24 DELI

Softline reported for 2023 by RAS

4/3/24 SOFL